Pulmonx Corporation
LUNG
$1.62
-$0.01-0.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.50M | 23.86M | 22.54M | 23.77M | 20.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.50M | 23.86M | 22.54M | 23.77M | 20.39M |
| Cost of Revenue | 5.45M | 6.66M | 6.20M | 6.18M | 5.36M |
| Gross Profit | 16.05M | 17.20M | 16.34M | 17.59M | 15.03M |
| SG&A Expenses | 25.60M | 26.70M | 26.15M | 27.01M | 25.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.90M | 38.66M | 37.10M | 37.18M | 34.52M |
| Operating Income | -14.39M | -14.80M | -14.56M | -13.42M | -14.13M |
| Income Before Tax | -13.83M | -15.00M | -14.31M | -13.14M | -13.95M |
| Income Tax Expenses | 128.00K | 177.00K | 135.00K | 38.00K | 192.00K |
| Earnings from Continuing Operations | -13.96M | -15.17M | -14.45M | -13.18M | -14.14M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.96M | -15.17M | -14.45M | -13.18M | -14.14M |
| EBIT | -14.39M | -14.80M | -14.56M | -13.42M | -14.13M |
| EBITDA | -14.15M | -14.51M | -14.29M | -13.12M | -13.75M |
| EPS Basic | -0.34 | -0.38 | -0.36 | -0.33 | -0.36 |
| Normalized Basic EPS | -0.21 | -0.23 | -0.22 | -0.21 | -0.22 |
| EPS Diluted | -0.34 | -0.38 | -0.36 | -0.33 | -0.36 |
| Normalized Diluted EPS | -0.21 | -0.23 | -0.22 | -0.21 | -0.22 |
| Average Basic Shares Outstanding | 40.94M | 40.43M | 39.95M | 39.58M | 39.28M |
| Average Diluted Shares Outstanding | 40.94M | 40.43M | 39.95M | 39.58M | 39.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |